231 related articles for article (PubMed ID: 17323836)
21. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis.
Greenstein JI
Dev Neurobiol; 2007 Aug; 67(9):1248-65. PubMed ID: 17514718
[TBL] [Abstract][Full Text] [Related]
22. DNA-based vaccines: the future of multiple sclerosis therapy?
Stüve O; Cravens PD; Eagar TN
Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
[TBL] [Abstract][Full Text] [Related]
23. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against light neurofilaments in multiple sclerosis patients.
Bartos A; Fialová L; Soukupová J; Kukal J; Malbohan I; Pitha J
Acta Neurol Scand; 2007 Aug; 116(2):100-7. PubMed ID: 17661795
[TBL] [Abstract][Full Text] [Related]
25. PD-L1 (B7-H1) regulation in zones of axonal degeneration.
Lipp M; Brandt C; Dehghani F; Kwidzinski E; Bechmann I
Neurosci Lett; 2007 Oct; 425(3):156-61. PubMed ID: 17825988
[TBL] [Abstract][Full Text] [Related]
26. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H
Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.
Rieckmann P; Mäurer M
Curr Opin Neurol; 2002 Jun; 15(3):361-70. PubMed ID: 12045738
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapeutic approaches in multiple sclerosis.
Adorini L
J Neurol Sci; 2004 Aug; 223(1):13-24. PubMed ID: 15261555
[TBL] [Abstract][Full Text] [Related]
29. [Recent prognosis on etiology and pathophysiology of multiple sclerosis].
Niino M
Nihon Rinsho; 2013 May; 71(5):807-10. PubMed ID: 23777086
[TBL] [Abstract][Full Text] [Related]
30. Multiple sclerosis genetics: leaving no stone unturned.
Oksenberg JR; Barcellos LF
Genes Immun; 2005 Aug; 6(5):375-87. PubMed ID: 15973459
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
[TBL] [Abstract][Full Text] [Related]
32. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
33. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
Grigoriadis N; Grigoriadis S; Polyzoidou E; Milonas I; Karussis D
Clin Neurol Neurosurg; 2006 Mar; 108(3):241-4. PubMed ID: 16388896
[TBL] [Abstract][Full Text] [Related]
34. New insights into adaptive immunity in chronic neuroinflammation.
Siffrin V; Brandt AU; Herz J; Zipp F
Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
[TBL] [Abstract][Full Text] [Related]
35. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
36. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
Lim ET; Giovannoni G
Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
[TBL] [Abstract][Full Text] [Related]
37. Potassium channels, memory T cells, and multiple sclerosis.
Beeton C; Chandy KG
Neuroscientist; 2005 Dec; 11(6):550-62. PubMed ID: 16282596
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Cammarota G; Mirabella M; Attilio Tonali P; Batocchi AP
Hum Immunol; 2008 Dec; 69(12):837-9. PubMed ID: 18940217
[TBL] [Abstract][Full Text] [Related]
39. Pathogenic T cell cytokines in multiple sclerosis.
Wagner CA; Roqué PJ; Goverman JM
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31611252
[TBL] [Abstract][Full Text] [Related]
40. Lessons from multiple sclerosis: models, concepts, observations.
Wekerle H
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
